Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry)
Copyright © 2021 Elsevier Inc. All rights reserved..
Long term survival and its determinants after Percutaneous Coronary Intervention (PCI) on Unprotected Left Main Coronary Artery (ULMCA) remain to be appraised. In 9 European Centers 470 consecutive patients performing PCI on ULMCA between 2002 and 2005 were retrospectively enrolled. Survival from all cause and cardiovascular (CV) death were the primary end points, while their predictors at multivariate analysis the secondary ones. Among the overall cohort 81.5% of patients were male and mean age was 66 ± 12 years. After 15 years (IQR 13 to 16), 223 patients (47%) died, 81 (17.2%) due to CV etiology. At multivariable analysis, older age (HR 1.06, 95%CI 1.02 to 1.11), LVEF < 35% (HR 2.97, 95%CI 1.24 to 7.15) and number of vessels treated during the index PCI (HR 1.75, 95%CI 1.12 to 2.72) were related to all-cause mortality, while only LVEF <35% (HR 4.71, 95%CI 1.90 to 11.66) to CV death. Repeated PCI on ULMCA occurred in 91 (28%) patients during the course of follow up and did not significantly impact on freedom from all-cause or CV mortality. In conclusion, in a large, unselected population treated with PCI on ULMCA, 47% died after 15 years, 17% due to CV causes. Age, number of vessels treated during index PCI and depressed LVEF increased risk of all cause death, while re-PCI on ULMCA did not impact survival.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:156 |
|---|---|
| Enthalten in: |
The American journal of cardiology - 156(2021) vom: 01. Okt., Seite 72-78 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 20.09.2021 Date Revised 31.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.amjcard.2021.06.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328704806 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328704806 | ||
| 003 | DE-627 | ||
| 005 | 20231225203515.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.amjcard.2021.06.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1095.xml |
| 035 | |a (DE-627)NLM328704806 | ||
| 035 | |a (NLM)34325877 | ||
| 035 | |a (PII)S0002-9149(21)00566-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a D'Ascenzo, Fabrizio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Long-term (≥15 years) Follow-up of Percutaneous Coronary Intervention of Unprotected Left Main (From the GRAVITY Registry) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.09.2021 | ||
| 500 | |a Date Revised 31.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
| 520 | |a Long term survival and its determinants after Percutaneous Coronary Intervention (PCI) on Unprotected Left Main Coronary Artery (ULMCA) remain to be appraised. In 9 European Centers 470 consecutive patients performing PCI on ULMCA between 2002 and 2005 were retrospectively enrolled. Survival from all cause and cardiovascular (CV) death were the primary end points, while their predictors at multivariate analysis the secondary ones. Among the overall cohort 81.5% of patients were male and mean age was 66 ± 12 years. After 15 years (IQR 13 to 16), 223 patients (47%) died, 81 (17.2%) due to CV etiology. At multivariable analysis, older age (HR 1.06, 95%CI 1.02 to 1.11), LVEF < 35% (HR 2.97, 95%CI 1.24 to 7.15) and number of vessels treated during the index PCI (HR 1.75, 95%CI 1.12 to 2.72) were related to all-cause mortality, while only LVEF <35% (HR 4.71, 95%CI 1.90 to 11.66) to CV death. Repeated PCI on ULMCA occurred in 91 (28%) patients during the course of follow up and did not significantly impact on freedom from all-cause or CV mortality. In conclusion, in a large, unselected population treated with PCI on ULMCA, 47% died after 15 years, 17% due to CV causes. Age, number of vessels treated during index PCI and depressed LVEF increased risk of all cause death, while re-PCI on ULMCA did not impact survival | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 700 | 1 | |a Elia, Edoardo |e verfasserin |4 aut | |
| 700 | 1 | |a Marengo, Giorgio |e verfasserin |4 aut | |
| 700 | 1 | |a Wańha, Wojciech |e verfasserin |4 aut | |
| 700 | 1 | |a González Ferreiro, R |e verfasserin |4 aut | |
| 700 | 1 | |a Truffa, Alessandra |e verfasserin |4 aut | |
| 700 | 1 | |a Trabattoni, Daniela |e verfasserin |4 aut | |
| 700 | 1 | |a Figini, Filippo |e verfasserin |4 aut | |
| 700 | 1 | |a Verardi, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Di Palma, G |e verfasserin |4 aut | |
| 700 | 1 | |a Infusino, Fabio |e verfasserin |4 aut | |
| 700 | 1 | |a Pivato, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Ochała, Andrzej |e verfasserin |4 aut | |
| 700 | 1 | |a Omedè, Pierluigi |e verfasserin |4 aut | |
| 700 | 1 | |a Milewski, Marek |e verfasserin |4 aut | |
| 700 | 1 | |a Estevez, Roi |e verfasserin |4 aut | |
| 700 | 1 | |a Raporeiras Roubin, S |e verfasserin |4 aut | |
| 700 | 1 | |a De Filippo, O |e verfasserin |4 aut | |
| 700 | 1 | |a Conrotto, Federico |e verfasserin |4 aut | |
| 700 | 1 | |a Montefusco, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Gili, Sebastiano |e verfasserin |4 aut | |
| 700 | 1 | |a Cortese, Bernardo |e verfasserin |4 aut | |
| 700 | 1 | |a Dusi, Veronica |e verfasserin |4 aut | |
| 700 | 1 | |a Gallone, Guglielmo |e verfasserin |4 aut | |
| 700 | 1 | |a Manfredi, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Mancone, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Biondi Zoccai, G |e verfasserin |4 aut | |
| 700 | 1 | |a Casella, Gianni |e verfasserin |4 aut | |
| 700 | 1 | |a Templin, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a Stefanini, Giulio |e verfasserin |4 aut | |
| 700 | 1 | |a Wojakowski, Wojciech |e verfasserin |4 aut | |
| 700 | 1 | |a Sheiban, Imad |e verfasserin |4 aut | |
| 700 | 1 | |a De Ferrari, G M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The American journal of cardiology |d 1958 |g 156(2021) vom: 01. Okt., Seite 72-78 |w (DE-627)NLM000025364 |x 1879-1913 |7 nnns |
| 773 | 1 | 8 | |g volume:156 |g year:2021 |g day:01 |g month:10 |g pages:72-78 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.amjcard.2021.06.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 156 |j 2021 |b 01 |c 10 |h 72-78 | ||